Results 181 to 190 of about 31,418 (244)
Ponsegromab: The new miracle drug for cancer cachexia.
Paikray E, Rout A, Tripathy R.
europepmc +1 more source
CXCL5 neutralization mitigates cancer cachexia by disrupting CAF-cancer cell crosstalk. [PDF]
Kim HJ +10 more
europepmc +1 more source
A straightforward one‐step protocol enables the synthesis of bio‐based and biologically active isochromans through the Oxa‐Pictet cyclization involving diverse aldehydes, including vanillin in combination with lignin‐derivable homovanillyl alcohol, a prominent aromatic platform chemical obtainable via diol‐assisted fractionation of lignocellulose ...
Anjali Kottayi +6 more
wiley +1 more source
Physical Activity, Exerkines, and Their Role in Cancer Cachexia. [PDF]
Bilski J +3 more
europepmc +1 more source
Abstract On the centennial of higher education in Chemical Engineering in Mexico, it is pertinent to revisit the key stages that have contributed to its consolidation as a vital discipline for the nation's scientific and technological advancement. Although the initial mission of chemical engineering education was primarily oriented toward the training ...
Agustín López Munguía +3 more
wiley +1 more source
This research explored South African iron‐rich sand (SAIRS) as a natural catalyst for light‐mediated wet peroxide oxidation of methyl orange dye in wastewater and at an optimized of conditions of 3500 mg/L catalyst dose, 6 mM H2O2, and pH 2.5, SAIRS achieved 94% methyl orange degradation within 90 min under visible light.
Aaliyah Ebrahim +3 more
wiley +1 more source
Reframing cancer cachexia: the vagal brain-liver axis as a novel neuro-metabolic target. [PDF]
Wei D, Lin X, Bresalier RS.
europepmc +1 more source
ABSTRACT Microtubules play essential roles in numerous cellular processes. All microtubules are built from the protein tubulin, yet individual microtubules can differ spatially and temporally due to their tubulin isotype composition and post‐translational modifications (PTMs).
Ezekiel C. Thomas +5 more
wiley +1 more source
ABSTRACT Lipid nanoparticles (LNPs) represent the most clinically advanced platform for RNA delivery and have enabled major breakthroughs in vaccines and gene therapies. However, their broader application is still limited by inefficient extrahepatic delivery, immunogenicity, and insufficient control over tissue‐ and cell‐specific targeting. This review
Yu Han +5 more
wiley +1 more source

